rs78916708

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024105.4(ALG12):​c.469+13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0177 in 1,612,618 control chromosomes in the GnomAD database, including 308 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 22 hom., cov: 33)
Exomes 𝑓: 0.018 ( 286 hom. )

Consequence

ALG12
NM_024105.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.453

Publications

2 publications found
Variant links:
Genes affected
ALG12 (HGNC:19358): (ALG12 alpha-1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 22 family. The encoded protein catalyzes the addition of the eighth mannose residue in an alpha-1,6 linkage onto the dolichol-PP-oligosaccharide precursor (dolichol-PP-Man(7)GlcNAc(2)) required for protein glycosylation. Mutations in this gene have been associated with congenital disorder of glycosylation type Ig (CDG-Ig)characterized by abnormal N-glycosylation. [provided by RefSeq, Jul 2008]
ALG12 Gene-Disease associations (from GenCC):
  • ALG12-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 22-49910421-G-A is Benign according to our data. Variant chr22-49910421-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261686.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0134 (2047/152358) while in subpopulation EAS AF = 0.0248 (129/5192). AF 95% confidence interval is 0.0214. There are 22 homozygotes in GnomAd4. There are 1026 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG12NM_024105.4 linkc.469+13C>T intron_variant Intron 4 of 9 ENST00000330817.11 NP_077010.1
ALG12XM_017028936.2 linkc.469+13C>T intron_variant Intron 4 of 9 XP_016884425.1
ALG12XM_017028937.2 linkc.469+13C>T intron_variant Intron 4 of 10 XP_016884426.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG12ENST00000330817.11 linkc.469+13C>T intron_variant Intron 4 of 9 1 NM_024105.4 ENSP00000333813.5

Frequencies

GnomAD3 genomes
AF:
0.0135
AC:
2048
AN:
152240
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00345
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.0107
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.0248
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.0323
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0177
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.0160
AC:
3949
AN:
247344
AF XY:
0.0156
show subpopulations
Gnomad AFR exome
AF:
0.00282
Gnomad AMR exome
AF:
0.0130
Gnomad ASJ exome
AF:
0.00181
Gnomad EAS exome
AF:
0.0229
Gnomad FIN exome
AF:
0.0303
Gnomad NFE exome
AF:
0.0190
Gnomad OTH exome
AF:
0.0204
GnomAD4 exome
AF:
0.0182
AC:
26523
AN:
1460260
Hom.:
286
Cov.:
32
AF XY:
0.0177
AC XY:
12854
AN XY:
726388
show subpopulations
African (AFR)
AF:
0.00278
AC:
93
AN:
33446
American (AMR)
AF:
0.0127
AC:
568
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
38
AN:
26120
East Asian (EAS)
AF:
0.0405
AC:
1607
AN:
39650
South Asian (SAS)
AF:
0.00515
AC:
444
AN:
86176
European-Finnish (FIN)
AF:
0.0320
AC:
1686
AN:
52622
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5764
European-Non Finnish (NFE)
AF:
0.0190
AC:
21097
AN:
1111514
Other (OTH)
AF:
0.0159
AC:
961
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1487
2973
4460
5946
7433
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0134
AC:
2047
AN:
152358
Hom.:
22
Cov.:
33
AF XY:
0.0138
AC XY:
1026
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00344
AC:
143
AN:
41580
American (AMR)
AF:
0.0106
AC:
163
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.0248
AC:
129
AN:
5192
South Asian (SAS)
AF:
0.00518
AC:
25
AN:
4828
European-Finnish (FIN)
AF:
0.0323
AC:
343
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0177
AC:
1206
AN:
68038
Other (OTH)
AF:
0.0114
AC:
24
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
107
213
320
426
533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0116
Hom.:
2
Bravo
AF:
0.0118
Asia WGS
AF:
0.0130
AC:
44
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 20, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALG12-congenital disorder of glycosylation Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.29
DANN
Benign
0.69
PhyloP100
-0.45
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78916708; hg19: chr22-50304069; COSMIC: COSV58206255; COSMIC: COSV58206255; API